× Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies

× Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population

× An old disease, a new diagnosis; A 49 year-old man with nephrotic syndrome

× Self-limited membranous nephropathy after intravitreal bevacizumab therapy for age-related macular degeneration

× Anti-phospholipase A2 receptor antibody positive hepatitis B virus-associated membranous nephropathy remitted with entecavir after relapse with lamivudine

× Phospholipase A2 receptor (PLA2R) related membranous nephropathy - not specific for idiopathic cases any more

× Infant onset systemic lupus erythematosus presenting as nephrotic syndrome

× Mycophenolate mofetil versus cyclophosphamide for idiopathic membranous nephropathy; a double blind and randomized clinical trial

× Efficacy and safety of a modified- ‘modified Ponticelli’ regimen for treatment of primary membranous nephropathy 

× The use of modified Ponticelli regimens for primary membranous nephropathy

× Multifaceted role of apolipoprotein L1 risk variants and nephropathy

× Membranous nephropathy with light chain restriction

× Case series of low dose rituximab for membranous nephropathy; a single centre experience